Elephas

Elephas has developed a transformative technology that evaluates the likelihood of response to immunotherapy. The Elephas Live™ platform is an ex vivo platform to help predict how a tumor will respond to immunotherapy. We use proprietary technology to preserve the native tumor microenvironment from a live core needle biopsy and perform a unique sequential treatment strategy to measure cytokine response. Results are delivered in a secure online portal.